Genetic insights support PARP1 as a mediator in the protective association of ATP-citrate lyase inhibitors with melanoma

Abstract ATP-citrate lyase (ACLY) inhibitors emerge as a promising anti-cancer strategy, yet their causal effects across various cancer types remain unclear. Here, we employ a drug-target Mendelian randomization (MR) approach using four cis-expression quantitative trait loci for blood ACLY gene expr...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiawen Lu, Gloria Hoi-Yee Li, Jingyi Hu, Zhenqian Wang
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Communications Biology
Online Access:https://doi.org/10.1038/s42003-025-07860-z
Tags: Add Tag
No Tags, Be the first to tag this record!